90 Participants Needed

Neuraxial Anesthesia for Surgery

EH
Overseen ByEmily Hladkowicz, PhD (c)
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ottawa Hospital Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. However, if you are on anticoagulants, they may need to be held for a certain period based on guidelines.

What data supports the effectiveness of the treatment Neuraxial Anesthesia for surgery?

Research shows that neuraxial anesthesia, which includes spinal and epidural anesthesia, can reduce the risk of complications and death after surgery. It is also popular for helping patients recover faster and move around sooner after surgery.12345

Is neuraxial anesthesia generally safe for humans?

Neuraxial anesthesia, which includes spinal and epidural anesthesia, is generally considered safe, but there are rare risks of serious complications like cardiac arrest, neurological damage, and infections. Most complications are uncommon, and the practice requires careful management to minimize risks.678910

How is neuraxial anesthesia different from other treatments for surgery?

Neuraxial anesthesia, which includes spinal and epidural anesthesia, is unique because it provides pain relief by blocking nerve signals in specific areas of the body, allowing for increased patient mobility and quicker recovery compared to general anesthesia. It is particularly beneficial for surgeries where targeted pain relief is needed without affecting the entire body.2341112

What is the purpose of this trial?

The ALOFT Pilot Trial will evaluate three pragmatic elements (recruitment, adherence, and follow-up) of neuraxial versus general anesthesia for lower limb revascularization surgery that are necessary to support a successful, large-scale evaluation. We will concurrently use implementation science methodology to further refine processes for the larger trial.The future full ALOFT trial will be designed to evaluate the comparative effectiveness of two different anesthesia types for improving outcomes.

Research Team

Dr. Daniel I McIsaac | Faculty of Medicine

Daniel McIsaac, MD

Principal Investigator

The Ottawa Hospital

Eligibility Criteria

The ALOFT Pilot Trial is for adults over 18 who are scheduled for lower limb revascularization surgery, like arterial bypass or angioplasty. Participants need to be able to use a phone for follow-up. It's not specified who can't join the trial.

Inclusion Criteria

I am scheduled for surgery to improve blood flow in my legs.
Able to access a telephone for postoperative follow-up

Exclusion Criteria

I have multiple sclerosis or a similar nerve condition.
A doctor has decided I'm not fit for this study's random selection process.
I need surgery due to an injury to an artery caused by trauma.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo lower limb revascularization surgery with either neuraxial or general anesthesia

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after surgery, including assessments at 30 days, 90 days, and 1 year

1 year
Multiple visits (in-person and virtual)

Extension

Long-term follow-up to assess health-related quality of life and other outcomes

1 year

Treatment Details

Interventions

  • Neuraxial Anesthesia
Trial Overview This pilot study tests neuraxial anesthesia against general anesthesia in surgeries for Peripheral Arterial Disease. It aims to assess recruitment, adherence, and follow-up processes needed for a larger future trial on anesthesia effectiveness.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Intervention arm participants will be allocated to neuraxial anesthesia. The specific approach (spinal, epidural, or combined spinal and epidural) will be at the discretion of the treating anesthesiologist, as the underlying physiologic mechanisms and impacts are similar for both approaches. Allowing clinician discretion will reflect routine standard of care practice and support generalizability. Specific choice of neuraxial anesthetic medications, doses, and adjuncts will also be at the discretion of the attending anesthesiologist, supporting pragmatism. While existing randomized data do not suggest that the sedation level during neuraxial anesthesia leads to differences in outcomes, providers will be requested to maintain sedation at or below a 3 on the Observer's Assessment of Alertness/Sedation scale (OAAS; mild to moderate sedation consistent to responding to verbal stimuli), the same approach used in a recent large pragmatic trial of anesthesia in hip fracture patients.
Group II: ControlActive Control1 Intervention
Control group participants will be allocated to general anesthesia. Choice of anesthetic medications and doses will be at the discretion of each anesthesiologist as per routine standard of care, again supporting conduct of a pragmatic and generalizable trial. Similarly, choice of airway management strategies and anesthetic depth will also be based on patient and provider preference, as a recent large randomized trial demonstrates that anesthetic depth is not causally linked to risk of morbidity or mortality after surgery. Details of general anesthesia management and medications will be collected for all patients.

Neuraxial Anesthesia is already approved in European Union, United States, Canada, Japan for the following indications:

🇪🇺
Approved in European Union as Neuraxial Anaesthesia for:
  • Lower limb revascularization surgery
  • Pain management
🇺🇸
Approved in United States as Neuraxial Anaesthesia for:
  • Lower limb revascularization surgery
  • Pain management
  • Obstetric procedures
🇨🇦
Approved in Canada as Neuraxial Anaesthesia for:
  • Lower limb revascularization surgery
  • Pain management
🇯🇵
Approved in Japan as Neuraxial Anaesthesia for:
  • Lower limb revascularization surgery
  • Pain management

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ottawa Hospital Research Institute

Lead Sponsor

Trials
585
Recruited
3,283,000+

The Ottawa Hospital Academic Medical Association

Collaborator

Trials
24
Recruited
3,000+

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1,417
Recruited
26,550,000+

University of Ottawa

Collaborator

Trials
231
Recruited
267,000+

Findings from Research

Neuraxial blockade, including epidural and spinal anesthesia, significantly reduces overall mortality by about one-third in postoperative patients, as shown in a systematic review of 141 trials involving 9559 patients.
This technique also lowers the risk of serious complications such as deep vein thrombosis (44% reduction), pulmonary embolism (55% reduction), and respiratory depression (59% reduction), suggesting it is a safer option compared to general anesthesia.
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.Rodgers, A., Walker, N., Schug, S., et al.[2023]
Neuraxial anesthesia, including spinal and epidural techniques, has evolved from being an alternative to general anesthesia to a preferred method for managing perioperative pain, particularly due to the safe and effective use of opioids for spinal analgesia.
The systematic review highlights that improvements in overall perioperative safety enhance the effectiveness of neuraxial analgesia, although the literature analysis reveals inconsistencies that make it challenging to draw definitive conclusions.
Does the evidence support the use of spinal and epidural anesthesia for surgery?Ballantyne, JC., Kupelnick, B., McPeek, B., et al.[2018]
Spinal and epidural anesthesia are effective methods for managing pain during certain surgical procedures, contributing to increased patient mobility and faster discharge times.
Neuraxial blocks are suitable for surgeries where the desired sensory level can be achieved safely, highlighting their growing popularity in regional anesthesia.
Postoperative considerations of neuraxial anesthesia.Cwik, J.[2012]

References

Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. [2023]
Does the evidence support the use of spinal and epidural anesthesia for surgery? [2018]
Postoperative considerations of neuraxial anesthesia. [2012]
Recent advances in epidural analgesia. [2021]
Does the impact of the type of anesthesia on outcomes differ by patient age and comorbidity burden? [2019]
[Complications of local and regional anesthesia. An analysis of closed files of insurance companies]. [2006]
Haematoma, abscess or meningitis after neuraxial anaesthesia in the USA and the Netherlands: A closed claims analysis. [2021]
Complications and controversies of regional anaesthesia: a review. [2021]
Safety in anaesthesia: a study of 12,606 reported incidents from the UK National Reporting and Learning System. [2022]
Pneumocephalus Following an Accidental Dural Puncture, Treated Using Hyperbaric Oxygen Therapy. A Case Report. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Epidural and Spinal Anesthesia for Newborn Surgery. [2020]
Regional and neuraxial anaesthesia techniques for spinal surgery: a scoping review. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security